Apple has taken a significant step forward in hearing health in the United States. The latest model of the AirPods Pro received authorization from Food and Drug Administration (FDA) the American federal agency responsible for regulating food and drugs, to be marketed as clinical grade hearing aid .
According to the Cupertino company, the new AirPods Pro 2 feature will boost frequencies to make sounds clearer and more vibrant. In addition, it will use machine learning to adapt in real time to users’ routines, providing a personalized listening experience.
More affordable alternative
Prescription hearing aids in the United States tend to be expensive. Priced at $249 (approximately R$2,599), the AirPods Pro 2 are a more affordable option for people with mild to moderate hearing loss.
It is important to note that the new AirPods Pro 2 feature is only intended for individuals with mild to moderate hearing loss. The level of loss will be assessed through sounds played through the earbuds themselves, ensuring that the device is used properly and effectively.
Apple’s history in the medical field
This isn’t Apple’s first foray into the medical field. The Apple Watch already has a feature to detect heart arrhythmia, and the latest version of the smartwatch now alerts users to sleep apnea, demonstrating the company’s continued commitment to health innovation.
The approval of AirPods Pro 2 as a clinical hearing aid marks a significant advancement at the intersection of consumer technology and medical devices.
Although currently limited to cases of mild to moderate hearing loss, this development paves the way for future innovations that could benefit a broader spectrum of patients with hearing problems.
This content was originally published in Apple’s AirPods Pro receives authorization to function as a hearing aid on the CNN Brasil website.
Source: CNN Brasil

Charles Grill is a tech-savvy writer with over 3 years of experience in the field. He writes on a variety of technology-related topics and has a strong focus on the latest advancements in the industry. He is connected with several online news websites and is currently contributing to a technology-focused platform.